ConductScience.org, home

Paper7585585

Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.

Wali RK and 9 others. Cancer Res, 1995. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta. Papers, record 7585585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7585585

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.
PubMed
Journal
Cancer Res
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
2.25
iCite
Revised in PubMed
2013-11-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wali RKR K
2Frawley BP JrB P
3Hartmann SS
4Roy HKH K
5Khare SS
6Scaglione-Sewell BAB A
7Earnest DLD L
8Sitrin MDM D
9Brasitus TAT A
10Bissonnette MM

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anticarcinogenic AgentsMajor topic
Colonic NeoplasmsMajor topic
IsoenzymesMajor topic
Protein Kinase CMajor topic
Ursodeoxycholic AcidMajor topic
Animals
Azoxymethane
Cholic Acid
Cholic Acids
Male
Rats
Rats, Inbred F344

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 36745NCI NIH HHSUnited StatesR01CA036745PubMed and NIHNIH RePORTER
CA 41108NCI NIH HHSUnited StatesP01CA041108PubMed and NIHNIH RePORTER
DK 42086NIDDK NIH HHSUnited StatesP30DK042086PubMed and NIHNIH RePORTER
R37CA036745NIHNIH RePORTER

Download CSV of grants

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
41051952Hepatic protein kinase Cβ antagonizing p38MAPK to activate ERK1/2 to dysregulate biliary lipid composition upon lithogenic stress.Am J Physiol Gastrointest Liver Physiol2025https://conductscience.org/library/papers/41051952PubMed
26939849Consequences of bile salt biotransformations by intestinal bacteria.Gut Microbes2016https://conductscience.org/library/papers/26939849PubMed
26770670A review of the medical treatment of primary sclerosing cholangitis in the 21st century.Ther Adv Chronic Dis2016https://conductscience.org/library/papers/26770670PubMed
24852569In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.Am J Physiol Gastrointest Liver Physiol2014https://conductscience.org/library/papers/24852569PubMed
24799986Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.World J Hepatol2014https://conductscience.org/library/papers/24799986PubMed
22785210
C1B domain peptide of protein kinase Cγ significantly suppresses growth of human colon cancer cells in vitro and in an in vivo mouse xenograft model through induction of cell cycle arrest and apoptosis.
Cancer Biol Ther2012https://conductscience.org/library/papers/22785210PubMed
22475628Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.J Biomed Sci2012https://conductscience.org/library/papers/22475628PubMed
21556038High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.Am J Gastroenterol2011https://conductscience.org/library/papers/21556038PubMed
20729391Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.Carcinogenesis2010https://conductscience.org/library/papers/20729391PubMed
20194350Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor.Carcinogenesis2010https://conductscience.org/library/papers/20194350PubMed
19446582Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR.Biochim Biophys Acta2009https://conductscience.org/library/papers/19446582PubMed
16434969Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.Oncogene2006https://conductscience.org/library/papers/16434969PubMed
11856477Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.Jpn J Cancer Res2002https://conductscience.org/library/papers/11856477PubMed
10330400Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis.J Cell Biol1999https://conductscience.org/library/papers/10330400PubMed
9849578Prevention of N-methylnitrosourea-induced colon tumorigenesis by ursodeoxycholic acid in F344 rats.Jpn J Cancer Res1998https://conductscience.org/library/papers/9849578PubMed
9824590Chemoprevention of colorectal cancer.Gut1998https://conductscience.org/library/papers/9824590PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7585585

GET https://conductscience.org/api/papers/v1/7585585/authors